Adjunct GLP-1 receptor agonist use in patients with Type 1 Diabetes

被引：0
|
作者：
Harkin, P. [1 ]
Crowley, R. [1 ]
McKenna, M. [1 ]
Canavan, R. [1 ]
Callanan, I [1 ]
Connolly, M. [1 ]
O'Shea, D. [1 ]
机构：
[1] St Vincents Hosp Dublin, Dept Endocrinol, Dublin, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2018年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P69
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 50 条
  • [1] Effect of the GLP-1 Receptor Agonist, Liraglutide as an Adjunct to Insulin Treatment in a Rodent Model of Type 1 Diabetes
    Meek, Thomas H.
    Kumar, Monica
    Matsen, Miles E.
    Fischer, Jonathan D.
    Taborsky, Gerald J., Jr.
    Schwartz, Michael W.
    Morton, Gregory J.
    [J]. DIABETES, 2013, 62 : A733 - A733
  • [2] Rationale Use of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes
    Jeff Unger
    [J]. Current Diabetes Reports, 2013, 13 : 663 - 668
  • [3] Rationale Use of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes
    Unger, Jeff
    [J]. CURRENT DIABETES REPORTS, 2013, 13 (05) : 663 - 668
  • [4] Semaglutide GLP-1 receptor agonist Treatment of type 2 diabetes
    Chudleigh, R.
    Bain, S. C.
    [J]. DRUGS OF THE FUTURE, 2017, 42 (08) : 479 - 487
  • [5] Dulaglutide, a GLP-1 receptor agonist, for the treatment of type 2 diabetes
    Clements, Jennifer
    Moore, Katherine
    Shealy, Kayce
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (06) : 581 - 590
  • [6] Effects of the GLP-1 Receptor Agonist on Fatty Liver in Patients With Type 2 Diabetes
    Ogino, Jun
    Yoneda, Chihiro
    Tajima, Kanako
    Ichimura, Yasuhiko
    Fukushima, Sayaka
    Haruki, Takenori
    Sakuma, Yukie
    Iwai, Rie
    Nishino, Takayoshi
    Suzuki, Yoshifumi
    Hashimoto, Naotake
    [J]. DIABETES, 2013, 62 : A256 - A257
  • [7] GLP-1 Receptor Agonist Discontinuation Among Patients With Obesity and/or Type 2 Diabetes
    Do, Duy
    Lee, Tiffany
    Peasah, Samuel K.
    Good, Chester B.
    Inneh, Angela
    Patel, Urvashi
    [J]. JAMA NETWORK OPEN, 2024, 7 (05)
  • [8] PREDICTION OF RESPONSE TO GLP-1 RECEPTOR AGONIST THERAPY IN JAPANESE PATIENTS WITH TYPE 2 DIABETES
    Imai, K.
    Tsujimoto, T.
    Goto, A.
    Goto, M.
    Kishimoto, M.
    Yamamoto-Honda, R.
    Noto, H.
    Kajio, H.
    Noda, M.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S258 - S259
  • [9] Prediction of response to GLP-1 receptor agonist therapy in Japanese patients with type 2 diabetes
    Imai, Kenjiro
    Tsujimoto, Tetsuro
    Goto, Atsushi
    Goto, Maki
    Kishimoto, Miyako
    Yamamoto-Honda, Ritsuko
    Noto, Hiroshi
    Kajio, Hiroshi
    Noda, Mitsuhiko
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2014, 6
  • [10] Prediction of response to GLP-1 receptor agonist therapy in Japanese patients with type 2 diabetes
    Kenjiro Imai
    Tetsuro Tsujimoto
    Atsushi Goto
    Maki Goto
    Miyako Kishimoto
    Ritsuko Yamamoto-Honda
    Hiroshi Noto
    Hiroshi Kajio
    Mitsuhiko Noda
    [J]. Diabetology & Metabolic Syndrome, 6
12345